Navigation Links
Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference
Date:2/15/2008

FORT LAUDERDALE, Fla., Feb. 15 /PRNewswire-FirstCall/ -- Ener1, Inc. (OTC Bulletin Board: ENEI) today announced that its Chief Financial Officer, Jerry Herlihy, will deliver an investor presentation at the Roth Capital 20th Annual OC Growth Conference at 10:00 A.M. Pacific Standard Time on Thursday, February 21st. The conference is being held over three days at the Ritz Carlton Laguna Niguel in Dana Point, California. The conference will feature presentations from over 300 small-cap companies in the Media, Technology, Telecommunications, Healthcare, Consumer, Energy, and Industrial sectors, in addition to one-on-one meetings with leading institutional investors. The Conference will also host a special panel on investing in Green Tech on Wednesday, February 20 at 10:00 A.M. Pacific Standard Time. Ener1 is one of thirty companies presenting at the conference that are designated as "Green Track."

(Logo: http://www.newscom.com/cgi-bin/prnh/20040825/FLW010LOGO )

The live webcast can be viewed at http://www.wsw.com/webcast/roth16/enei.ob/ or on the Company's website at http://www.ener1.com

About Ener1, Inc.

Ener1, Inc. (OTC Bullein Board: ENEI) is leading the North American development and commercialization of advanced, high-performance safe lithium ion (Li-ion) batteries for hybrid electric vehicles (HEVs), Plug-in HEVs (PHEVs) and Electric Vehicles (EVs). Ener1 also is developing commercial fuel cell products through its EnerFuel subsidiary and nanotechnology-based materials and manufacturing processes for batteries and other applications at its NanoEner subsidiary. For more information, visit http://www.ener1.com and http://www.enerdel.com or call 954-556-4020.

Contact: Michael Mason (investor relations)

Allen & Caron Inc

212 691 8087

michaelm@allencaron.com

Jerry Herlihy (Ener1)

954 556-4020 x310

Jherlihy@ener1.com


'/>"/>
SOURCE Ener1, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
2. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
3. drugstore.com, inc. to Present at the Upcoming Jefferies 4th Annual Internet Conference and the Morgan Stanley Technology Conference
4. China Display Technologies, Inc. to Present at Roth Conference
5. DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference
6. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
7. Cardiac Science to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
8. A Sneak Peek Into the Special Needs Home of Tomorrow - Renowned Autism Consultant Valerie Herskowitz to Present Latest Findings at Autism Through the Lifespan Conference February 14-17 in Orlando
9. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
10. Berkery Noyes Represented The Riverside Company on the Sale of HCPro Holdings, Inc. to Halyard Capital, LLC
11. Pharmacopeia to Present at The Roth 20th Annual OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert ... Core benefits and advantages built into the home office sit stand solution are ... feel. Ability to gain the benefits embedded in the TaskMate Go are available ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. Hawkins, vice ... appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new ... 10. Dr. Bell comes to Liberty from the Ohio University Heritage College of ...
(Date:2/24/2017)... ... ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” (published by ... Schanssema describes the tragedies he saw, as well as his struggles with grief and ... unsure of the career path he wanted to take, found fulfillment in a career ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced ... the Chairman of the Management Committee when IFN was originally formed in 2002 where ... investor/owners and development of the business plan. He became the first paid employee ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning ... Gran Fondo of Marin. For the second year in a row, cyclists will ... , “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Autism Spectrum Disorder Drugs Price Analysis ... the global Autism Spectrum Disorder market. The research answers the ... drugs marketed for Autism Spectrum Disorder and their clinical attributes? How ...
Breaking Medicine Technology: